Percutaneous Osseointegrated Docking System for Above Elbow Amputees
Percutaneous Osseointegrated Docking System for Above Elbow Amputees
批准号:
9188778
负责人:
Kent N. Bachus
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-11-01 至 2018-10-31
关键词:
AddressAgeAmputationAmputeesAnatomyAnimal ModelAreaBlast CellCadaverClinicalClinical TrialsComputer-Aided DesignDataDermalDeteriorationDevelopmentDevicesDimensionsDockingElbowEngineeringFemurFreezingGenderGoalsHealthcareHealthcare SystemsHeterotopic OssificationHumanHuman ResourcesImageImplantLengthLimb structureLocationMathematicsMeasuresMilitary PersonnelModernizationMorphologyPatientsPersistent painPersonsPopulationPostoperative PeriodProtocols documentationQuality of lifeRaceRecovery of FunctionRehabilitation therapyResearch DesignResidual stateSamplingSeriesSheepSystemTechniquesThickTissuesTorsionTrainingTraumaTraumatic AmputationUnited StatesUpper ExtremityVeteransWorkX-Ray Computed Tomographybasebonedesignexpectationexperienceimplant designimprovedinstrumentationlimb amputationmetallicitypatient populationprototypepublic health relevancereconstructionresidual limbsample fixationsealsoft tissuestandard of caretranslation to humansvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The overall goal of this three-year project is to maximize the functional recovery of patients with
above elbow amputations (AEA) by developing an intramedullary Percutaneous Osseointegrated Docking System (PODS) that is ready for translation to human clinical trials. The design of the AEA PODS will address the challenges found in above elbow residual limbs of modern day warfighters (i.e. short residual limbs, heterotopic ossification (HO), shrapnel). Background: Socket-type attachment of an exoprosthesis to the residual limb is currently the standard of care, but is not suitable for all patients. Even patients successfully fitted with sockt-type attachments can be dissatisfied since they frequently experience pain from persistent deterioration of the soft tissues resulting from poor socket fit. In addition, blast related heterotopic ossification (HO) within the soft tissues of the residual limb cause further reductions
in quality of life. It is for these kinds of patients that PODS devices are developed. There are three Specific Aims to this proposal. First, using morphological data from a pooled cadaver population with the diversity of personnel currently serving active duty for the United States, we will engineer a series of AEA PODS endoprostheses. We have a proven track record with this type of work not only with translational animal models, but also with human femurs for an upcoming FDA small feasibility clinical trial with AKA patients. In this project, we will deliver a
series of AEA PODS sufficient to achieve a 95% confidence of fitting the pooled cadaver population. Second, we will verify the endoprosthetic fit of the AEA PODS using a sample population of de-identified VA and military patients with traumatic amputations. To date, PODS have not been designed to account for the unique clinical challenges found in both the VA and the military healthcare populations. Working directly with collaborators within the VA, the WRNMMC, and the BAMC healthcare systems, we will obtain de-identified CT image sets from trauma related AEA populations. By evaluating the designed AEA PODS using a sample patient population, we will be able to verify that the designs are adequate to preserve endoprosthetic fit of this unique population. We will deliver a series of AEA PODS sufficient to achieve a 95% confidence of fitting a sample patient population. Third, we will establish the initial post-operatve fixation expectations for AEA PODS. We believe that before rehabilitation of AEA PODS patients can safely be initiated, it is imperative to determine the relationship between the measured endoprosthetic fit of the AEA PODS endoprostheses and the expected post-operative fixation. We will deliver a mathematical relationship to estimate, within 95% confidence, the initial post-operative fixation of AEA PODS given the endoprosthetic fit. Study Design: Using our established protocols used to develop endoprosthesis for previous sheep animal models and upcoming FDA Feasibility trials for AKA PODS devices, we will engineer a series of AEA PODS sufficient to achieve a 95% confidence of fitting a sample AEA patient population and develop a mathematical relationship to estimate, within 95% confidence, the initial post-operative fixation of AEA PODS given the endoprosthetic fit. Relevance: In the development of PODS devices, patients with traumatic amputations above the elbow are currently underserved. As of 02 July 2012, the number of patients from OIF/OEF with major limb amputations has reached 1,506, of which 263 (17%) suffer from upper extremity involvement. Nationally, it is estimated in 2005, of the 1.5 million persons living with limb loss in 2005, 541,000 (36%) have an upper extremity involvement. Unfortunately, rejection of socket-type exoprosthetics is especially prevalent in AEA patients. Nearly 60% of AEA patients reject the use of their socket-based exoprosthesis because of issues such as poor fit, difficulties with training, limited usefulness, and short residual limb-length.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RR&D Research Career Scientist Award Application
-
批准号:10543085
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Kent N. Bachus
-
依托单位:
RR&D Research Career Scientist Award Application
-
批准号:10386762
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Kent N. Bachus
-
依托单位:
Functional Expectations of Transhumeral Percutaneous Osseointegration Patients.
-
批准号:9929447
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Kent N. Bachus
-
依托单位:
Functional Expectations of Transhumeral Percutaneous Osseointegration Patients.
-
批准号:10475095
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Kent N. Bachus
-
依托单位:
Functional Expectations of Transhumeral Percutaneous Osseointegration Patients.
-
批准号:10833462
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Kent N. Bachus
-
依托单位:
Functional Expectations of Transhumeral Percutaneous Osseointegration Patients.
-
批准号:10261447
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Kent N. Bachus
-
依托单位:
Negative Pressure Wound Therapy to Soft Tissues Surrounding Percutaneous Devices
-
批准号:9248815
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Kent N. Bachus
-
依托单位:
Negative Pressure Wound Therapy to Soft Tissues Surrounding Percutaneous Devices
-
批准号:8866571
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Kent N. Bachus
-
依托单位:
Negative Pressure Wound Therapy to Soft Tissues Surrounding Percutaneous Devices
-
批准号:9046399
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Kent N. Bachus
-
依托单位:
Percutaneous Osseointegrated Docking System for Above Elbow Amputees
-
批准号:8782802
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Kent N. Bachus
-
依托单位:
Percutaneous Osseointegrated Docking System for Above Elbow Amputees
-
批准号:9026502
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Kent N. Bachus
-
依托单位:
Predicting Skeletal Stability of Endoprostheses for Above Elbow Amputees
-
批准号:8155331
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Kent N. Bachus
-
依托单位:
Predicting Skeletal Stability of Endoprostheses for Above Elbow Amputees
-
批准号:8001687
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Kent N. Bachus
-
依托单位:
Infection-Prevention Barriers for Osseointegrated Percutaneous Implants
-
批准号:8044706
-
项目类别:
-
资助金额:$35.76万
-
财政年份:2009
-
负责人:Kent N. Bachus
-
依托单位:
Infection-Prevention Barriers for Osseointegrated Percutaneous Implants
-
批准号:7786978
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2009
-
负责人:Kent N. Bachus
-
依托单位:
Infection-Prevention Barriers for Osseointegrated Percutaneous Implants
-
批准号:7664852
-
项目类别:
-
资助金额:$36.69万
-
财政年份:2009
-
负责人:Kent N. Bachus
-
依托单位:
Infection-Prevention Barriers for Osseointegrated Percutaneous Implants
-
批准号:8225185
-
项目类别:
-
资助金额:$35.76万
-
财政年份:2009
-
负责人:Kent N. Bachus
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: